Melan-A/MART-1/AS02B/ Montanide ISA vaccine (Ludwig Institute for Cancer Research)

N/A

Report date: 2023/06/26 09:15:32

Base Information

Drug NameMelan-A/MART-1/AS02B/ Montanide ISA vaccine (Ludwig Institute for Cancer Research)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcAir Liquide HealthcareLudwig Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAir Liquide HealthcareGlaxosmithkline PlcLudwig Institute For Cancer Research
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A